Hematology Preclinical Deal Benchmarks — Ex-US (2026)
Median upfront of $35M with total deal values reaching $635M in Ex-US territory.
Median Upfront
$35M
Total Deal Value
$397M
Royalty Range
3.4%–7.6%
Territory Multiplier
0.45x
Understanding Hematology Deal Benchmarks at Preclinical
Preclinical Hematology licensing deals in Ex-US territory command a median upfront payment of $35M, with values ranging from $11M at the low end to $63M for premium assets. These benchmarks reflect the risk-adjusted value of clinical-stage assets in the hematology therapeutic area, where development costs, competitive dynamics, and market potential all factor into deal pricing.
Full Market Analysis
Detailed deal economics, territory impact analysis, and royalty structure breakdown.
We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.
7-day money-back guarantee · Cancel anytime
Full Benchmark Data
Full Benchmark Table
Low, median, and high ranges for upfront payments, total deal values, and royalty rates.
We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.
7-day money-back guarantee · Cancel anytime
Comparable Deals
See All Comparable Deals
View 1 comparable Hematology transactions with upfront payments, total values, and deal structures.
We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.
7-day money-back guarantee · Cancel anytime
Frequently Asked Questions
What is the average upfront payment for Preclinical Hematology deals in Ex-US territory?
More Expert Insights
Territory impact analysis, royalty negotiation strategies, and deal structure guidance.
We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.
7-day money-back guarantee · Cancel anytime
Related Benchmarks
$91M upfront
Hematology · Phase 1 · Ex-US
$275M upfront
Hematology · Phase 2 · Ex-US
$907M upfront
Hematology · Phase 3 · Ex-US
$2.4B upfront
Hematology · Approved · Ex-US
$15M upfront
Oncology · Preclinical · Ex-US
$15M upfront
Neurology/CNS · Preclinical · Ex-US
$32M upfront
Immunology · Preclinical · Ex-US
$35M upfront
Metabolic/Obesity · Preclinical · Ex-US
Run Your Own Benchmark
These benchmarks are starting points. Get a customized valuation for your specific asset, indication, and deal structure.
Open Deal CalculatorCite This Data
Ambrosia Ventures. (2026). Hematology Preclinical Deal Benchmarks — Ex-US (2026). Retrieved from https://calculator.ambrosiaventures.co/data/hematology-preclinical-deals-ex-us
<a href="https://calculator.ambrosiaventures.co/data/hematology-preclinical-deals-ex-us">Hematology Preclinical Deal Benchmarks — Ex-US (2026)</a> — Ambrosia Ventures (2026)
<iframe src="https://calculator.ambrosiaventures.co/api/embed/chart?type=phase-upfront&ta=hematology&theme=light" width="600" height="400" frameborder="0" style="border:1px solid #e2e8f0;border-radius:12px;"></iframe>
Data sourced from 1,900+ verified biopharma transactions. Updated monthly.